Prism Johnson FY26 EBITDA Surges 52% to ₹693 Cr; Net Debt Nearly Halved to ₹646 Cr

5 min read     Updated on 14 May 2026, 04:20 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Prism Johnson reported FY26 consolidated EBITDA of ₹693 crore (+52.1% YoY) on revenue of ₹7,404 crore (+8.4% YoY), with effective net debt reducing sharply to ₹646 crore from ₹1,138 crore. Standalone net profit turned around to ₹55.99 crore from a net loss of ₹102.19 crore in FY25. All three segments—Prism Cement, HRJ, and Prism RMC—delivered improved full-year performance, while the company progressed its strategic exit from Raheja QBE for ₹324 crore.

powered bylight_fuzz_icon
39801926

*this image is generated using AI for illustrative purposes only.

Prism Johnson Limited has announced its audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, with the Board of Directors approving the results at its meeting held on May 14, 2026. The company closed FY26 on a stronger footing, delivering improvements across all three businesses—Prism Cement, H & R Johnson (HRJ), and Prism RMC—alongside significant balance sheet deleveraging.

Consolidated Financial Highlights

On a consolidated basis (excluding Raheja QBE), Prism Johnson reported revenue of ₹7,404 crore for FY26, reflecting growth of 8.4% year-on-year (YoY). Consolidated EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) surged 52.1% YoY to ₹693 crore. The company's effective net debt reduced sharply to ₹646 crore at the end of FY26, compared to ₹1,138 crore at the end of FY25, strengthening its financial position. Free Cash Flow (pre-capex and investments), excluding the cash outflow of ₹404 crore towards payment of Financial Obligations, stood at ₹738 crore in FY26. On a reported consolidated basis, net profit for FY26 stood at ₹30.01 crore, compared to ₹45.11 crore in the previous year, while total consolidated income rose to ₹7,415.68 crore from ₹6,939.63 crore.

The following table summarises the key consolidated financial metrics:

Metric: FY26 FY25 Change
Revenue (Ex. RQBE): ₹7,404 crore +8.4% YoY
EBITDA (Ex. RQBE): ₹693 crore +52.1% YoY
Effective Net Debt: ₹646 crore ₹1,138 crore Reduced
Free Cash Flow (Pre-Capex): ₹738 crore
Total Consolidated Income: ₹7,415.68 crore ₹6,939.63 crore
Consolidated Net Profit: ₹30.01 crore ₹45.11 crore

Q4 FY26 Operational Highlights

For the quarter ended March 31, 2026, Prism Johnson reported revenue of ₹21 billion, compared to ₹19.5 billion in the same quarter of the previous year. However, EBITDA for the quarter came in at ₹1.75 billion versus ₹1.97 billion in the corresponding prior-year period, with the EBITDA margin contracting to 8.30% from 10.10% YoY. On a consolidated basis, the Q4 net profit stood at ₹280 million, a sharp decline compared to ₹1.35 billion in the same quarter last year, while the consolidated net loss on a reported basis was ₹15.95 crore for the quarter.

Metric: Q4 FY26 Q4 FY25
Revenue: ₹21B ₹19.5B
EBITDA: ₹1.75B ₹1.97B
EBITDA Margin: 8.30% 10.10%
Consolidated Net Profit: ₹280M ₹1.35B

Standalone Financial Performance

For the full financial year ended March 31, 2026, Prism Johnson reported a standalone net profit of ₹55.99 crore, marking a significant turnaround from the net loss of ₹102.19 crore recorded in the previous year. Total income for the year rose to ₹7,355.47 crore from ₹6,857.05 crore in FY25. Revenue from operations stood at ₹7,254.41 crore, compared to ₹6,697.40 crore in the prior year. For the quarter ended March 31, 2026, the company reported a standalone net loss of ₹47.44 crore, primarily due to exceptional items amounting to ₹79.03 crore largely attributed to the impairment of investment in Raheja QBE General Insurance Company Limited. Excluding exceptional items, the profit before tax for the quarter was ₹23.98 crore.

Particulars: Year ended March 31, 2026 (₹ Crores) Year ended March 31, 2025 (₹ Crores)
Total Income: 7,355.47 6,857.05
Total Expenses: 7,296.39 6,960.29
Net Profit / (Loss): 55.99 (102.19)
Earnings Per Share (₹): 1.11 2.03

Segment Performance

Prism Johnson operates across three main segments—Cement, HRJ, and RMC—all of which delivered improved performance in FY26. The following table presents the key segment-wise highlights:

Segment: Revenue FY26 YoY Growth EBITDA FY26 EBITDA Margin FY26
Prism Cement: ₹3,405 crore +12.7% ₹401.6 crore
H & R Johnson (HRJ): ₹2,447 crore +2.3% ₹178.7 crore 7.3%
Prism RMC: ₹1,551 crore +9.6% ₹113 crore 7.3%

Prism Cement delivered strong full-year earnings with EBITDA per tonne increasing to ₹543 from ₹351 in FY25, supported by disciplined cost management. Q4 FY26 EBITDA per tonne moderated to ₹337 from ₹579 in Q4 FY25, primarily due to a scheduled maintenance shutdown that was strategically shifted to the Q3–Q4 period to align with Alternative Fuel and Raw Materials (AFR) initiatives. Cement and clinker sales volume grew 5.7% YoY to 2.1 million tonnes in Q4 FY26, with the share of premium products increasing to 62% from 46% in Q4 FY25. ROCE for Prism Cement stood at 16.7% in FY26.

H & R Johnson delivered steady revenue growth of 2.3% YoY to ₹2,447 crore in FY26, with EBITDA improving 27.7% YoY to ₹178.7 crore and margins expanding by 145 basis points to 7.3%. In Q4 FY26, tile operations at Morbi were impacted by disruptions arising from the Middle East crisis; however, the company sustained revenue growth through inventory reduction. Tiles Division revenue grew 5.2% YoY to ₹598 crore in Q4 FY26, while Bath Division revenue increased 17.1% YoY to ₹109 crore. EBITDA margin improved by 147 basis points YoY to 9.8% in Q4 FY26. ROCE for HRJ stood at 4.7% in FY26.

Prism RMC delivered revenue growth of 9.6% YoY to ₹1,551 crore in FY26, with EBITDA increasing 37.2% YoY to ₹113 crore. Margins expanded by 146 basis points from 5.8% in FY25 to 7.3% in FY26. Q4 FY26 revenues grew 16.8% YoY to ₹439 crore, driven by higher volumes in the Commercial Concrete segment. Total volumes (Commercial + Mega) increased 3.7% YoY to 10.1 lakh m³ in Q4 FY26, with the Mega Projects order book standing at approximately 13.5 lakh m³.

Strategic Exit from Raheja QBE & Exceptional Items

Prism Johnson has entered into an agreement to exit its insurance joint venture, Raheja QBE General Insurance Company Limited, through the sale of its entire 51% stake to existing partner QBE Holdings (AAP) Pty Limited for ₹324 crore (subject to certain adjustments on completion of the transaction as per the Share Purchase Agreement). Shareholder and IRDAI approvals have been received, and the transaction is expected to be completed in the next few weeks. As the transaction was not concluded by March 31, 2026, the investment was classified as a non-current asset held for sale, resulting in an impairment charge of ₹79.03 crore, which contributed to the standalone net loss of ₹47.44 crore for Q4 FY26.

Historical Stock Returns for Prism Johnson

1 Day5 Days1 Month6 Months1 Year5 Years
-0.95%-0.03%-10.07%-12.75%-14.94%-9.73%

How will the proceeds from the ₹324 crore Raheja QBE stake sale be deployed—toward further debt reduction, capital expenditure, or shareholder returns?

With Prism Cement's EBITDA per tonne dropping sharply in Q4 FY26 due to maintenance shutdowns, how quickly can the AFR initiatives restore margins to full-year levels in FY27?

Given H & R Johnson's exposure to Morbi tile operations, what is the company's contingency strategy if Middle East trade disruptions persist or intensify through FY27?

Prism Johnson Board Approves Fund Raising of Up to ₹500 Crores via Equity Securities and ₹1,250 Crores via NCDs

2 min read     Updated on 14 May 2026, 03:43 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Prism Johnson Limited's Board of Directors, at its meeting on May 14, 2026, approved raising up to ₹500 Crores through equity shares and equity-linked instruments via various permissible modes, and up to ₹1,250 Crores through Secured/Unsecured Redeemable Non-convertible Debentures on a private placement basis. Both proposals are subject to shareholder approval at the ensuing Annual General Meeting and applicable statutory and regulatory approvals. The specific mode of issuance for equity securities and detailed terms for NCDs will be determined by the Board of Directors or the Fund Raising Committee at the relevant time.

powered bylight_fuzz_icon
40299201

*this image is generated using AI for illustrative purposes only.

The Board of Directors of Prism Johnson Limited convened a meeting on May 14, 2026, and approved two significant fund-raising proposals pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting commenced at 10.30 a.m. and concluded at 01.40 p.m. The approvals follow an earlier intimation dated May 8, 2026, and are subject to shareholder approval at the ensuing Annual General Meeting, along with all applicable statutory and regulatory approvals.

Fund-Raising Proposals at a Glance

The board approved two distinct fund-raising avenues, covering both equity and debt instruments. The key parameters of each proposal are summarised below:

Parameter: Equity / Equity-Linked Securities Non-Convertible Debentures (NCDs)
Securities Type: Equity shares, convertible preference shares, non-convertible debt instruments with warrants, fully/partly convertible debentures, warrants, or other eligible securities Secured/Unsecured Redeemable Non-convertible Debentures, including Bonds and/or other Debt Securities
Aggregate Amount (Not Exceeding): ₹500 Crores ₹1,250 Crores
Mode of Issuance: Further public issue, private placement, qualified institutions placement, preferential issue, rights issue, or any combination thereof Private Placement basis
Tranches: One or more tranches and/or one or more issuances One or more tranches/series
Type of Issuance (Specific): To be decided by the Board of Directors or Fund Raising Committee from time to time Preferential Allotment
Investor Details: To be decided by the Board of Directors or Fund Raising Committee from time to time To be decided by the Board of Directors at the relevant time of issuance

Equity and Equity-Linked Securities

Under the first proposal, the board approved the creation, offer, issuance, and allotment of equity shares and equity-linked instruments for an aggregate amount not exceeding ₹500 Crores. The instruments covered under this proposal include:

  • Equity shares
  • Convertible preference shares
  • Non-convertible debt instruments along with warrants
  • Fully convertible debentures
  • Partly convertible debentures
  • Warrants entitling holders to apply for equity shares
  • Any other eligible securities

The issuance may be carried out through a further public issue, private placement, qualified institutions placement, preferential issue, rights issue, or any permissible combination thereof, in one or more tranches. The specific mode of issuance will be determined by the Board of Directors or the Fund Raising Committee of the company from time to time. The proposal is in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended.

Non-Convertible Debentures

The second proposal authorises the issuance of Secured/Unsecured Redeemable Non-convertible Debentures (NCDs), including Bonds and/or other Debt Securities, on a private placement basis for an aggregate amount not exceeding ₹1,250 Crores. The NCDs may be issued in one or more tranches or series to eligible investors. The issuance is in accordance with the Securities and Exchange Board of India (Issue and Listing of Non-Convertible Securities) Regulations, 2021, as amended. Specific details pertaining to the size, listing, tenure, coupon/interest, and security/charge over assets will be decided by the Board of Directors at the time of issuance.

Shareholder and Regulatory Approvals

Both fund-raising proposals are subject to the approval of the company's shareholders, which will be sought at the ensuing Annual General Meeting. Additionally, all applicable statutory and regulatory approvals are required before the proposals can be implemented. The disclosures have been made in compliance with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, with detailed annexures submitted to the stock exchanges as required under Regulation 30 of the SEBI LODR.

Historical Stock Returns for Prism Johnson

1 Day5 Days1 Month6 Months1 Year5 Years
-0.95%-0.03%-10.07%-12.75%-14.94%-9.73%

How might Prism Johnson deploy the ₹1,750 crores raised through equity and NCD instruments, and which business segments—cement, tiles, or ready-mix concrete—are likely to benefit most from the capital infusion?

Given the preference for private placement in the NCD issuance, which institutional investors or strategic partners is Prism Johnson likely to target, and how might this affect its debt-to-equity ratio going forward?

How could the equity dilution of up to ₹500 crores impact existing shareholders' stake and earnings per share, particularly if the board opts for a qualified institutions placement or preferential issue?

More News on Prism Johnson

1 Year Returns:-14.94%